Clinical Trial Update: MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MR-guided radiotherapy dose escalation for esophageal squamous cell carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: UMC Utrecht | Conditions: Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Cancer, Squamous Cell | Phase 1 | Status: RECRUITING